Latest Research, Industry, Medical and Scientific News
Risk for symptoms of depression may be associated with urinary incontinence (UI) which was mediated by functional impairment among middle-aged and older adults. These findings, from a cross-sectional study, were published in the Journal of Affective Disorders. Read more.
Source: Psychiatry Advisor, July 27, 2022
Because of a decrease in estrogen, menopause is often accompanied by multiple vaginal and urinary issues. To date, most treatment options focus on vulvar and vaginal atrophy, with fewer options available to treat urinary incontinence. A new study, however, suggests prasterone is effective in improving the severity of urinary urge incontinence. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). Read more.
Source: Newswise, July 27, 2022
The impact and management of urinary incontinence (UI) related to overactive bladder is a substantial burden to long-term care (LTC) residents and staff, according to a study published online July 1 in the Journal of Gerontological Nursing. Richard G. Stefanacci, D.O., from Thomas Jefferson University in Philadelphia, and colleagues assessed the impact of UI on residents, staff, care processes, and quality measures in LTC settings. The analysis included responses from directors of nursing who had worked for at least one year in a ≥100-bed facility. Read more.
Source: Health Day News, July 25, 2022
First Quality has launched Boundless™ by Cuties®, a size 8 youth diaper for children with special needs who have outgrown baby diapers, but who are not yet ready for adult incontinence products. Boundless youth diapers aim to provide Complete Care for All, so that every child can feel confident and protected. The first-of-its-kind youth diaper provides the same protection as a baby diaper but is designed to fit the frame of children who are 58 lbs. or more and managing incontinence issues. Read more.
Source: PRNewswire, July 20, 2022
“Any knowledge that doesn’t lead to new questions quickly dies out: it fails to maintain the temperature required for sustaining life,” said poet and Nobel Laureate Wislawa Szymborska. Looking back at the past 50 years, I recounted the achievements and yet-to-be-conquered goals. It is also prudent to think back to what ideas/concepts have withstood the test of time, in the quest for knowledge and the inherent desire to replace old with new. Read more.
Source: Urology Times, June 16, 2022
Ipsen (Euronext: IPN; ADR: IPSEY) today announced that Dysport® (abobotulinumtoxinA) has received positive opinion in Europe for the management of urinary incontinence (UI) in adults with neurogenic detrusor overactivity (NDO) due to spinal cord injury (SCI) (traumatic or non-traumatic) or multiple sclerosis (MS), who are regularly performing clean intermittent catheterization (CIC). This positive opinion for Dysport® now permits individual European country Health Authorities to grant national approvals, according to their country regulations. In addition, Ipsen is also currently in the process of obtaining approvals in other countries outside the European Union. Read more.
Source: Globe Newswire, June 9, 2022